These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27643774)

  • 21. T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation.
    O'Riordan JI; Gawne Cain M; Coles A; Wang L; Compston DA; Tofts P; Miller DH
    Mult Scler; 1998 Oct; 4(5):408-12. PubMed ID: 9839300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
    Rüttinger H; Hermes M
    Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
    Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast.
    Tanaka M; Nakahara K; Kinoshita M
    Eur Neurol; 2016; 75(3-4):195-8. PubMed ID: 27054693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium contrast agent selection and optimal use for body MR imaging.
    Guglielmo FF; Mitchell DG; Gupta S
    Radiol Clin North Am; 2014 Jul; 52(4):637-56. PubMed ID: 24889165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
    Gowin W; Weihe W; Appel C; Mariss G
    Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314
    [No Abstract]   [Full Text] [Related]  

  • 27. Newer magnetic resonance techniques and disease activity in multiple sclerosis: new concepts and new concerns.
    Filippi M; Silver NC; Yousry TA; Miller DH
    Mult Scler; 1998 Dec; 4(6):469-70. PubMed ID: 9987753
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial.
    Wolansky LJ; Haghighi MH; Sevdalis E; Cook SD; Sethi N; Liu J; Joseph G; Tulloch K; Cadavid D
    J Neuroimaging; 2005 Jul; 15(3):289-90. PubMed ID: 15951416
    [No Abstract]   [Full Text] [Related]  

  • 29. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
    Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
    AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cationic gadolinium contrast agent for magnetic resonance imaging of cartilage.
    Freedman JD; Lusic H; Wiewiorski M; Farley M; Snyder BD; Grinstaff MW
    Chem Commun (Camb); 2015 Jun; 51(56):11166-11169. PubMed ID: 26051807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparing the activity of multiple sclerosis (MS) at the minute and at 20 minutes of gadolinium application in magnetic resonance imaging (MRI) of the brain?].
    Saldívar-Uribe C; de la Portilla-Villanueva MA; Esau-Mendoza-García A
    Gac Med Mex; 2017; 153(1):88-91. PubMed ID: 28128810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadolinium-based magnetic resonance imaging contrast agents in interventional radiology.
    Atar E
    Isr Med Assoc J; 2004 Jul; 6(7):412-4. PubMed ID: 15274532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients.
    Mattingly G; Baker K; Zorumski CF; Figiel GS
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):145-51. PubMed ID: 1627975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image interpretation session: 1997. Multiple sclerosis (MS).
    Radiographics; 1998; 18(1):224-8. PubMed ID: 9460126
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry.
    Bruder O; Schneider S; Nothnagel D; Pilz G; Lombardi M; Sinha A; Wagner A; Dill T; Frank H; van Rossum A; Schwitter J; Nagel E; Senges J; Sabin G; Sechtem U; Mahrholdt H
    JACC Cardiovasc Imaging; 2011 Nov; 4(11):1171-6. PubMed ID: 22093267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
    Bryan RN
    Radiology; 2015 May; 275(2):311-3. PubMed ID: 25906297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.
    Harris JO; Frank JA; Patronas N; McFarlin DE; McFarland HF
    Ann Neurol; 1991 May; 29(5):548-55. PubMed ID: 1859184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automatic detection of gadolinium-enhancing multiple sclerosis lesions in brain MRI using conditional random fields.
    Karimaghaloo Z; Shah M; Francis SJ; Arnold DL; Collins DL; Arbel T
    IEEE Trans Med Imaging; 2012 Jun; 31(6):1181-94. PubMed ID: 22318484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging using gadolinium-based contrast agents.
    Mitsumori LM; Bhargava P; Essig M; Maki JH
    Top Magn Reson Imaging; 2014 Feb; 23(1):51-69. PubMed ID: 24477166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.